Monimus Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$3.25M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$2.87M |
| 3 |
Dine Brands
DIN
|
+$2.73M |
| 4 |
Freshworks
FRSH
|
+$2.7M |
| 5 |
Tenable Holdings
TENB
|
+$2.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$3.27M |
| 2 |
Papa John's
PZZA
|
+$2.93M |
| 3 |
Dollar Tree
DLTR
|
+$2.7M |
| 4 |
Tapestry
TPR
|
+$2.39M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.47% |
| 2 | Technology | 13.58% |
| 3 | Healthcare | 11.35% |
| 4 | Consumer Staples | 10.54% |
| 5 | Communication Services | 9.29% |
Similar funds
Monimus Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Monimus Capital Management held 69 positions worth $162M, up 18% from $138M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Monimus Capital Management deployed $6.95M of net new capital in Q3 2025, opening 15 new positions and adding to 13 existing holdings. Its largest new stake was Bio-Techne: 60,742 shares worth $3.38M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Papa John's, an estimated $2.93M trimmed.
- Monimus Capital Management's largest Q3 2025 buy was Bio-Techne: 60,742 shares worth $3.38M.
- Monimus Capital Management added most to Dine Brands in Q3 2025, an estimated $2.73M increase.
- Monimus Capital Management's biggest Q3 2025 reduction was Papa John's, cutting an estimated $2.93M.
- Monimus Capital Management fully exited Airbnb in Q3 2025, selling an estimated $3.27M.
- Monimus Capital Management's ten largest holdings make up 43% of its $162M portfolio in Q3 2025.
- Monimus Capital Management opened 15 new positions and closed 10 in Q3 2025.
- Monimus Capital Management's portfolio value rose 18% quarter-over-quarter to $162M.
Based on Monimus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.